Tecartus Europska Unija - hrvatski - EMA (European Medicines Agency)

tecartus

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfom, mantel-stanica - antineoplastična sredstva - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Colcamexx 0,5 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

colcamexx 0,5 mg tablete

pharmaselect international beteiligungs gmbh, ernst-melchior gasse 20, beč, austrija - kolhicin - tableta - urbroj: svaka tableta sadrži 0,5 mg kolhicina

Colcamexx 1 mg tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

colcamexx 1 mg tablete

pharmaselect international beteiligungs gmbh, ernst-melchior gasse 20, beč, austrija - kolhicin - tableta - urbroj: svaka tableta sadrži 1 mg kolhicina